A. E. Eskazan, "Vascular Adverse Events During Long-term Nilotinib Therapy in Patients With Chronic Myeloid Leukemia," CLINICAL LYMPHOMA MYELOMA & LEUKEMIA , vol.17, no.12, 2017
Eskazan, A. E. 2017. Vascular Adverse Events During Long-term Nilotinib Therapy in Patients With Chronic Myeloid Leukemia. CLINICAL LYMPHOMA MYELOMA & LEUKEMIA , vol.17, no.12 .
Eskazan, A. E., (2017). Vascular Adverse Events During Long-term Nilotinib Therapy in Patients With Chronic Myeloid Leukemia. CLINICAL LYMPHOMA MYELOMA & LEUKEMIA , vol.17, no.12.
Eskazan, Ahmet. "Vascular Adverse Events During Long-term Nilotinib Therapy in Patients With Chronic Myeloid Leukemia," CLINICAL LYMPHOMA MYELOMA & LEUKEMIA , vol.17, no.12, 2017
Eskazan, Ahmet E. . "Vascular Adverse Events During Long-term Nilotinib Therapy in Patients With Chronic Myeloid Leukemia." CLINICAL LYMPHOMA MYELOMA & LEUKEMIA , vol.17, no.12, 2017
Eskazan, A. E. (2017) . "Vascular Adverse Events During Long-term Nilotinib Therapy in Patients With Chronic Myeloid Leukemia." CLINICAL LYMPHOMA MYELOMA & LEUKEMIA , vol.17, no.12.
@article{article, author={Ahmet Emre EŞKAZAN}, title={Vascular Adverse Events During Long-term Nilotinib Therapy in Patients With Chronic Myeloid Leukemia}, journal={CLINICAL LYMPHOMA MYELOMA & LEUKEMIA}, year=2017}